|
M.B. Antsiferov, N.A. Demidov, T.I. Safronova, O.A. Mishra
Efficacy and safety of fixed combination insulin glargine 100 u/ml and lixisenatide in patients with type 2 diabetes mellitus depending on age and baseline HbA1C in the SOLO study
|
№11-12 / 2022
|
|
M.S. Novikova, O.M. Koteshkova, M.B. Antsiferov
Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin
|
№4 / 2022
|
|
S.S. Apetov, V.V. Apetova
The role of menopausal hormone therapy in the prevention of type 2 diabetes melltus in postmenopausal women
|
№4 / 2022
|
|
A.D. Akulova (1), Yu.S. Zhulina (1), V.V. Rozhkova (1), E.Yu. Martynova (2), Yu.E. Poteshkin (1)
Problem of treatment adherence in patients with type 2 diabetes mellitus
|
№4 / 2022
|
|
A.F. Verbovoy, Yu.A. Dolgikh, N.I. Verbovaya, T.V. Lomonova
Obesity: an invisible disease
|
№12 / 2021
|
|
P.B. Shorokhova, V.L. Baranov
Differentiated approach to metformin therapy in newly diagnosed type 2 diabetes mellitus from the perspective of pharmacogenetics
|
№12 / 2021
|
|
N.A. Chernikova
β-cell dysfunction in type 2 diabetes mellitus: the possibilities of modern antihyperglycemic therapy
|
№12 / 2021
|
|
M.B. Antsiferov (1), O.M. Koteshkova (1), M.S. Novikova (1), N.A. Demidov (2)
Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus
|
№12 / 2021
|
|
N.I. Volkova, S.O. Panenko, A.O. Golubeva
Is non-alcoholic fatty liver disease a consequence of obesity and a predictor of diabetes?
|
№12 / 2021
|
|
N.A. Shevkunova (1), M.V. Vorobyov (2), V.V. Gushchin (2)
The use of collagen plates in orthopedic dental rehabilitation of patients with drug-compensated diabetes mellitus
|
№4 / 2021
|
|
A.S. Ametov (1), E.A. Tertychnaya (2)
Early pathogenetic combined therapy of sugar diabetes type 2: focus on insulin resistance
|
№14 / 2019
|
|
Extreme risk category in the stratification of cardiovascular complications. Consensus Council of experts
|
№4 / 2019
|
Русский
